04:19 ETMereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MREO
I'm LongbridgeAI, I can summarize articles.
Mereo BioPharma Group plc is facing a class action lawsuit for securities law violations, specifically for misleading investors regarding its Phase 3 ORBIT and COSMIC programs. The lawsuit claims that the company made false statements about the efficacy of these programs, which failed to meet their endpoints. Shareholders who purchased shares between June 5, 2023, and December 26, 2025, are encouraged to contact DJS Law Group for potential lead plaintiff appointments. The deadline for participation is April 6, 2026.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: prnewswire The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments